Pharmabiz18h
March Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...
Ryoncil® Commercial Launch Update And Product Pipeline
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the progress of the U.S. commercial launch of Ryoncil ® ...
manilatimes17h
Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy
Achieved Statistical Significance with Up to 48% Slowing of Clinical Progression on UMSARS Rating Scale - MELBOURNE, Australia and SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Alterity ...
NBC on MSN3h
Shameless Star Justin Chatwin Had a Pivotal Law & Order Role in a Heartbreaking Episode
Attorney Nolan Price found himself at odds with his brother, played by Chatwin, as the siblings were forced to make a painful ...
JD Supra11h
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...
Catalyst Pharmaceuticals stock hits all-time high of $24.44
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) shares soared to an all-time high this week, reaching a peak of $24.44. According to InvestingPro data, the company maintains an "EXCELLENT" financial ...
Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...
Effective Pharma Marketing Authorisation Application Training Course (ONLINE EVENT: February 5-6, 2025)
The "Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Training Course" conference has been added to ResearchAndMarkets.com's offering. The Common ...
Healthcare Contract Research Organization Market Size to Surpass USD 93.23 Billion by 2032, Growing at a 7.10% CAGR - SNS Insider
Global Healthcare CRO Market Growth is Driven by Rising Investments in R&D, Regulatory Complexity, and Adoption of Decentralized Clinical Trials.Pune, Jan. 30, 2025 (GLOBE NEWSWIRE) -- “According to ...